Monopar raises ~$37.6M via registered offering and private placement of pre-funded warrants

Monopar Therapeutics

Registered offering of 798,655 shares at $23.79 per share; concurrent private placement of pre-funded warrants for 882,761 shares at $23.789 each.
Pre-funded warrants have exercise price of $0.001 per share; total combined net proceeds ~$37.6M after discounts and expenses.
Closings expected December 23, 2024; underwriting agreement with Piper Sandler & Co. as representative.
Securities Purchase Agreement with an institutional investor; Registration Rights Agreement requires resale registration within 30 days of closing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.